Breaks Categories: News

WednesdayFeb 13, 2019 9:51 am

NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Signs Distributor for Hygee(TM) in Vietnam; Releases CBD Product Launch Update

Innovative biotechnology company Earth Science Tech (OTCQB: ETST) today announced a distribution agreement to market its Hygee(TM) medical device in Vietnam and provided an update on its CBD product line. According to the update, the company is nearing completion of its first commercial batch of Hygee and, for the next five years, Queen Concept Inc. will be the exclusive Hygee distributor in Vietnam with access to the stock needed for the Vietnamese market. In addition, the company announced the upcoming launch of three products, starting with the PropoDiol throat spray, a new formula developed as a joint venture with Laboratoire…

Continue Reading

WednesdayFeb 13, 2019 9:27 am

NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Extends Mineralization at Iron Creek Project; Intersects High Grade Copper

First Cobalt (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC), a North American pure-play cobalt company, this morning reported drill results extending the strike and width of the mineralized zones at its Iron Creek Cobalt Project. The results also identified additional copper-rich areas to the west of the deposit. Among other highlights, the company reported that the cobalt-copper mineralization was extended by 120 meters to the west along strike in the Waite Zone and to a depth of 300 meters. Results show that the western portion of the No Name Zone is distinctly copper-rich, having intercepted broad widths of copper mineralization including…

Continue Reading

TuesdayFeb 12, 2019 12:36 pm

NetworkNewsBreaks – NutraFuels, Inc. (NTFU) Acquires Patent for All-natural Insect Deterrent Patch; Forms New Subsidiary

NutraFuels (OTCQB: NTFU), soon to be NutraLife BioScience, Inc., this morning announced that it has acquired a patent for a unique and natural insect deterrent formulation that works via a dermal delivery system patch. The patented patch employs natural ingredients such as Vitamin B1 to avert mosquitoes and other insects. In January, NutraFuels founded a new wholly-owned subsidiary, NutraDerma Technologies, to commercialize the patch after reaching compliance with pertinent regulatory requirements. With the patented patch as the first planned product for the subsidiary, NutraDerma has effectively taken its first step in the direction of entering the bio life sciences market.…

Continue Reading

TuesdayFeb 12, 2019 9:53 am

NetworkNewsBreaks – Golden Developing Solutions, Inc. (DVLP) Announces Significant Progress Toward Launch of Colorado-Based Supercritical CO2 CBD Extraction Facility

Emerging leader in the cannabis, hemp, and cannabidiol (“CBD”) marketplace Golden Developing Solutions (OTC: DVLP) this morning announced significant progress toward establishment of its new Colorado-based high-capacity CBD extraction and production facility, including a pending equipment order for a best-in-class supercritical CO2 extraction system. Per the update, the system (CO2 rather than ethanol based) is designed to drive the highest purity levels in end production. DVLP management intends to finalize machinery orders within the next 90 days and expects the facility to be fully operational by summer of 2019. “We are committed to driving the bus, not just riding on…

Continue Reading

TuesdayFeb 12, 2019 9:36 am

NetworkNewsBreaks – Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Releases Q2 2019 Financial and Operating Results

Supreme Cannabis Company (TSX.V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) this morning announced the release of its financial and operating results for the three and six months ended December 31, 2018. According to the update, Q2 2019 highlights include: revenue of $7.72 million, reflecting a 359 percent increase from Q2 2018 and a 50 percent increase from Q1 2019; a net comprehensive loss of $1.55 million, compared net losses of $2.03 million in Q2 2018 and $5.39 million in Q1 2019. In addition, Supreme Cannabis strengthened its balance sheet during the quarter by raising gross proceeds of $100 million through a…

Continue Reading

TuesdayFeb 12, 2019 9:11 am

NetworkNewsBreaks – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Appoints New Member to Board of Directors

BriaCell Therapeutics (OTCQB: BCTXF) (TSX.V: BCT), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, this morning announced the appointment of Jamieson Bondarenko, CFA, CMT, to the company's Board of Directors. Through his merchant capital company, JGRNT Capital Corp., Bondarenko currently offers strategic capital markets and corporate development advice to early-stage life sciences companies. He has also served as Principal, Managing Director of Equity Capital Markets at Eight Capital and Equity Capital Markets as well as Investment Banking positions at Dundee Capital Markets, Wellington West Capital Markets and HSBC Securities. “Jamieson brings extensive capital markets experience to BriaCell,”…

Continue Reading

MondayFeb 11, 2019 10:07 am

NetworkNewsBreaks – Generation Alpha Inc. (GNAL) Appoints New Board Member to Assist in Expansion, Explore New Opportunities in Legal Cannabis Market

Vertically integrated cannabis company Generation Alpha Inc. (OTCQB: GNAL) this morning announced the appointment of international businessman and entrepreneur David Lenigas to its board of directors. Per the update, Lenigas has first-hand experience in the legalized medical cannabis sector, having assisted with funding the building of operations in Canada, Europe, Australia and Jamaica. In addition, he has extensive experience chairing and managing companies on many international stock exchanges.  “I am pleased to welcome David to the Board of Directors,” Generation Alpha CEO Alan Lien commented in the news release.  “David comes to us with an international entrepreneurial and capital markets…

Continue Reading

MondayFeb 11, 2019 9:58 am

NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) to Participate in National Cannabis Roundtable

Leading California edibles manufacturer Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) on February 8, 2019, announced its participation in the newly formed National Cannabis Roundtable (“NCR”), a campaign aimed at reforming federal cannabis laws and advocating for a rational legal framework. Former U.S. Speaker of the House John Boehner will serve as honorary chairman of the NCR. According to the update, the NCR public policy team, which includes The Liaison Group, Squire Patton Boggs and HDMK Public Affairs, will advocate for a multi-faceted reform agenda that includes: removal of federal restrictions that prohibit medical research involving cannabis; introduction of solutions…

Continue Reading

MondayFeb 11, 2019 9:40 am

NetworkNewsBreaks – Spectrum Global Solutions Inc. (SGSI) Utilizes Equity Investment to Reduce Outstanding Debt, Strengthen Balance Sheet

Spectrum Global Solutions Inc. (OTCQB: SGSI), a multi-national single-source provider of next-generation communications network professional services and software solutions to telecommunications and enterprise markets, this morning announced that it was able to utilize an equity investment received in connection with its previously announced WaveTech Global merger to satisfy the approximately $1.1 million debt owed to Libertas Funding LLC in connection with Spectrum’s acquisition of TNS. “Our ability to satisfy the Libertas debt within 30 calendar days saved the Company thousands of dollars and freed up additional cash that was being used for amortization payments,” Roger Ponder, CEO of Spectrum, stated…

Continue Reading

MondayFeb 11, 2019 8:45 am

NetworkNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Granted $1M by the Alzheimer’s Association to Advance Development of XPro1595

INmune Bio (NASDAQ: INMB) this morning announced that the company has been awarded a grant to receive $1,000,000 from the Alzheimer's Association to advance XPro1595 under the Part the Cloud to RESCUE grant. XPro1595 is a novel therapy targeting neuroinflammation as a cause of Alzheimer’s disease. The award will be paid to the company in traches during the phase 1 clinical trial. “We are honored to receive this grant from the Alzheimer’s Association,” RJ Tesi, M.D., CEO of INmune Bio stated in the news release. “The Alzheimer’s Association has shown the vision and leadership to support the quest for effective…

Continue Reading